Global Synthetic Biology Market 2022-2028

March 2022 | 80 pages | ID: GEEF4710CACEEN
Gen Consulting Company

Abstracts

Synthetic biology combines molecular biology and systems biology with engineering principles to design biological systems and bio-factories. Synthetic biology is driving significant advances in biomedicine, which will lead to transformational improvements in healthcare. According to latest analysis by Gen Consulting Company, the global synthetic biology market is projected to climb to USD 39,579 million by 2028-end, progressing at a CAGR of 19.7% during 2022-2028.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global synthetic biology market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the synthetic biology industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, application, and region. The global market for synthetic biology can be segmented by product: core products, enabling products, others. Synthetic biology market is further segmented by application: chemicals, food and agriculture, healthcare, research, others. Based on region, the synthetic biology market is segmented into: Asia Pacific, Europe, North America, Rest of the World (RoW).

By product:

• core products
• enabling products
• others

By application:

• chemicals
• food and agriculture
• healthcare
• research
• others

By region:

• Asia Pacific
• Europe
• North America
• Rest of the World (RoW)

The report also provides analysis of the key companies of the industry and their detailed company profiles including Agilent Technologies, Inc., Amyris, Inc., Danaher Corporation, DuPont de Nemours, Inc., GenScript Biotech Corporation, Koninklijke DSM N.V., New England Biolabs Inc., Novozymes A/S, Thermo Fisher Scientific Inc, Viridos (formerly Synthetic Genomics, Inc.), among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global synthetic biology market.
• To classify and forecast the global synthetic biology market based on product, application, region.
• To identify drivers and challenges for the global synthetic biology market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global synthetic biology market.
• To identify and analyze the profile of leading players operating in the global synthetic biology market.

Why Choose This Report

• Gain a reliable outlook of the global synthetic biology market forecasts from 2022 to 2028 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints
Impact of COVID-19 pandemic

PART 5. MARKET BREAKDOWN BY PRODUCT

Core products
Enabling products
Others

PART 6. MARKET BREAKDOWN BY APPLICATION

Chemicals
Food and agriculture
Healthcare
Research
Others

PART 7. MARKET BREAKDOWN BY REGION

Asia Pacific
Europe
North America
Rest of the World (RoW)

PART 8. KEY COMPANIES

Agilent Technologies, Inc.
Amyris, Inc.
Danaher Corporation
DuPont de Nemours, Inc.
GenScript Biotech Corporation
Koninklijke DSM N.V.
New England Biolabs Inc.
Novozymes A/S
Thermo Fisher Scientific Inc
Viridos (formerly Synthetic Genomics, Inc.)
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER